171 related articles for article (PubMed ID: 36841806)
1. NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation.
Zhang P; Chen L; Zhou F; He Z; Wang G; Luo Y
Cell Death Dis; 2023 Feb; 14(2):159. PubMed ID: 36841806
[TBL] [Abstract][Full Text] [Related]
2. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.
Li L; Hu Y; Chen D; Zhu J; Bao W; Xu X; Chen H; Chen W; Feng R
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34791506
[TBL] [Abstract][Full Text] [Related]
3. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway.
Ma X; Ren H; Zhang Y; Wang B; Ma H
Environ Toxicol; 2022 Dec; 37(12):3013-3027. PubMed ID: 36125241
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells.
Zhang S; Zhau HE; Osunkoya AO; Iqbal S; Yang X; Fan S; Chen Z; Wang R; Marshall FF; Chung LW; Wu D
Mol Cancer; 2010 Jan; 9():9. PubMed ID: 20085644
[TBL] [Abstract][Full Text] [Related]
5. The regulation of Neuropilin 1 expression by miR-338-3p promotes non-small cell lung cancer via changes in EGFR signaling.
Ding Z; Zhu J; Zeng Y; Du W; Zhang Y; Tang H; Zheng Y; Qin H; Liu Z; Huang JA
Mol Carcinog; 2019 Jun; 58(6):1019-1032. PubMed ID: 30811684
[TBL] [Abstract][Full Text] [Related]
6. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
[TBL] [Abstract][Full Text] [Related]
7. Neuropilin-1 contributes to esophageal squamous cancer progression via promoting P65-dependent cell proliferation.
Shi F; Shang L; Yang LY; Jiang YY; Wang XM; Hao JJ; Zhang Y; Huang DK; Cai Y; Xu X; Zhan QM; Jia XM; Cao Y; Wang MR
Oncogene; 2018 Feb; 37(7):935-943. PubMed ID: 29059172
[TBL] [Abstract][Full Text] [Related]
8. Neuropilin-1-dependent regulation of EGF-receptor signaling.
Rizzolio S; Rabinowicz N; Rainero E; Lanzetti L; Serini G; Norman J; Neufeld G; Tamagnone L
Cancer Res; 2012 Nov; 72(22):5801-11. PubMed ID: 22986738
[TBL] [Abstract][Full Text] [Related]
9. DUSP22 suppresses prostate cancer proliferation by targeting the EGFR-AR axis.
Lin HP; Ho HM; Chang CW; Yeh SD; Su YW; Tan TH; Lin WJ
FASEB J; 2019 Dec; 33(12):14653-14667. PubMed ID: 31693867
[TBL] [Abstract][Full Text] [Related]
10. Dual-targeting of EGFR and Neuropilin-1 attenuates resistance to EGFR-targeted antibody therapy in KRAS-mutant non-small cell lung cancer.
Kim YJ; Baek DS; Lee S; Park D; Kang HN; Cho BC; Kim YS
Cancer Lett; 2019 Dec; 466():23-34. PubMed ID: 31521695
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation.
Liu T; Xiang W; Chen Z; Wang G; Cao R; Zhou F; Meng Z; Luo Y; Chen L
Cell Death Dis; 2023 Nov; 14(11):774. PubMed ID: 38008826
[TBL] [Abstract][Full Text] [Related]
12. ErbB-2 signaling plays a critical role in regulating androgen-sensitive and castration-resistant androgen receptor-positive prostate cancer cells.
Muniyan S; Chen SJ; Lin FF; Wang Z; Mehta PP; Batra SK; Lin MF
Cell Signal; 2015 Nov; 27(11):2261-71. PubMed ID: 26257301
[TBL] [Abstract][Full Text] [Related]
13. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.
Hu B; Guo P; Bar-Joseph I; Imanishi Y; Jarzynka MJ; Bogler O; Mikkelsen T; Hirose T; Nishikawa R; Cheng SY
Oncogene; 2007 Aug; 26(38):5577-86. PubMed ID: 17369861
[TBL] [Abstract][Full Text] [Related]
14. Sin1 promotes proliferation and invasion of prostate cancer cells by modulating mTORC2-AKT and AR signaling cascades.
Huang Y; Feng G; Cai J; Peng Q; Yang Z; Yan C; Yang L; Wang Z
Life Sci; 2020 May; 248():117449. PubMed ID: 32088212
[TBL] [Abstract][Full Text] [Related]
15. MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways.
Tiemin P; Fanzheng M; Peng X; Jihua H; Ruipeng S; Yaliang L; Yan W; Junlin X; Qingfu L; Zhefeng H; Jian L; Zihao G; Guoxing L; Boshi S; Ming Z; Qinghui M; Desen L; Lianxin L
J Hepatol; 2020 Apr; 72(4):761-773. PubMed ID: 31837357
[TBL] [Abstract][Full Text] [Related]
16. Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality.
Tse BWC; Volpert M; Ratther E; Stylianou N; Nouri M; McGowan K; Lehman ML; McPherson SJ; Roshan-Moniri M; Butler MS; Caradec J; Gregory-Evans CY; McGovern J; Das R; Takhar M; Erho N; Alshalafa M; Davicioni E; Schaeffer EM; Jenkins RB; Ross AE; Karnes RJ; Den RB; Fazli L; Gregory PA; Gleave ME; Williams ED; Rennie PS; Buttyan R; Gunter JH; Selth LA; Russell PJ; Nelson CC; Hollier BG
Oncogene; 2017 Jun; 36(24):3417-3427. PubMed ID: 28092670
[TBL] [Abstract][Full Text] [Related]
17. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
Festuccia C; Muzi P; Millimaggi D; Biordi L; Gravina GL; Speca S; Angelucci A; Dolo V; Vicentini C; Bologna M
Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337
[TBL] [Abstract][Full Text] [Related]
18. The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer.
Blanc C; Moktefi A; Jolly A; de la Grange P; Gay D; Nicolaiew N; Semprez F; Maillé P; Soyeux P; Firlej V; Vacherot F; Destouches D; Amiche M; Terry S; de la Taille A; Londoño-Vallejo A; Allory Y; Delbé J; Hamma-Kourbali Y
Br J Cancer; 2023 Mar; 128(5):918-927. PubMed ID: 36550208
[TBL] [Abstract][Full Text] [Related]
19. RUNX2 overexpression and PTEN haploinsufficiency cooperate to promote CXCR7 expression and cellular trafficking, AKT hyperactivation and prostate tumorigenesis.
Bai Y; Yang Y; Yan Y; Zhong J; Blee AM; Pan Y; Ma T; Karnes RJ; Jimenez R; Xu W; Huang H
Theranostics; 2019; 9(12):3459-3475. PubMed ID: 31281490
[No Abstract] [Full Text] [Related]
20. HMGB1 Promotes Prostate Cancer Development and Metastasis by Interacting with Brahma-Related Gene 1 and Activating the Akt Signaling Pathway.
Lv DJ; Song XL; Huang B; Yu YZ; Shu FP; Wang C; Chen H; Zhang HB; Zhao SC
Theranostics; 2019; 9(18):5166-5182. PubMed ID: 31410208
[No Abstract] [Full Text] [Related]
[Next] [New Search]